Search

Your search keyword '"Lin, Bochao D."' showing total 45 results

Search Constraints

Start Over You searched for: Author "Lin, Bochao D." Remove constraint Author: "Lin, Bochao D." Search Limiters Full Text Remove constraint Search Limiters: Full Text
45 results on '"Lin, Bochao D."'

Search Results

1. Shared genetic basis between genetic generalized epilepsy and background electroencephalographic oscillations

3. Polygenic risk, familial liability and stress reactivity in psychosis: an experience sampling study

4. Gene-environment interaction study on the polygenic risk score for neuroticism, childhood adversity, and parental bonding

5. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia

6. Age- and sex-specific associations between risk scores for schizophrenia and self-reported health in the general population

7. Polygenic risk, familial liability and stress reactivity in psychosis: an experience sampling study

8. Context v. algorithm: Evidence that a transdiagnostic framework of contextual clinical characterization is of more clinical value than categorical diagnosis

9. Gene–environment interaction study on the polygenic risk score for neuroticism, childhood adversity, and parental bonding

10. Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

11. A polygenic-informed approach to a predictive EEG signature empowers antidepressant treatment prediction: A proof-of-concept study

12. Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway

13. A replication study of JTC bias, genetic liability for psychosis and delusional ideation

14. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia

16. What makes the psychosis 'clinical high risk' state risky: psychosis itself or the co-presence of a non-psychotic disorder?

17. Erratum:Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: Findings from a population-based study (BJPsych Open (2020) 6:5 (e87) DOI: 10.1192/bjo.2020.75)

18. A new genetic locus for antipsychotic-induced weight gain:A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)

19. Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?

20. Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia

21. Association of preceding psychosis risk states and non-psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS-2 cohort

22. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)

23. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study

24. What makes the psychosis ‘clinical high risk’ state risky: psychosis itself or the co-presence of a non-psychotic disorder?

26. Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?

27. Association of preceding psychosis risk states and non‐psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS‐2 cohort

28. Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

29. Assessing causal links between metabolic traits, inflammation and schizophrenia : a univariable and multivariable, bidirectional Mendelian-randomization study

30. White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

31. Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study

32. White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

33. White noise speech illusions: A trait-dependent risk marker for psychotic disorder?

34. Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability

35. White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

37. Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability

38. Genetic Susceptibility to Clozapine-Induced Agranulocytosis/Neutropenia Across Ethnicities: Results From a New Cohort of Turkish and Other Caucasian Participants, and Meta-Analysis.

39. Heritability and GWAS Studies for Monocyte-Lymphocyte Ratio

42. Genome-wide association meta-analysis of individuals of European ancestry identifies new loci explaining a substantial fraction of hair color variation and heritability

43. Associations Between Genetic Risk, Physical Activities, and Distressing Psychotic-like Experiences.

44. Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.

45. Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study.

Catalog

Books, media, physical & digital resources